| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 683-689, Copyright © 1993 by Endocrine Society
ARTICLES |
M Karl, SW Lamberts, SD Detera-Wadleigh, IJ Encio, CA Stratakis, DM Hurley, D Accili and GP Chrousos
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
The clinical syndrome of generalized, compensated glucocorticoid resistance is characterized by increased cortisol secretion without clinical evidence of hyper- or hypocortisolism, and manifestations of androgen and/or mineralocorticoid excess. This condition results from partial failure of the glucocorticoid receptor (GR) to modulate transcription of its target genes. We studied the molecular mechanisms of this syndrome in a Dutch kindred, whose affected members had hypercortisolism and approximately half of normal GRs, and whose proband was a young woman with manifestations of hyperandrogenism. Using the polymerase chain reaction to amplify and sequence each of the nine exons of the GR gene alpha, along with their 5'- and 3'-flanking regions, we identified a 4-base deletion at the 3'-boundary of exon 6 in one GR allele (delta 4), which removed a donor splice site in all three affected members studied. In contrast, the sequence of exon 6 in the two unaffected siblings was normal. A single nucleotide substitution causing an amino acid substitution in the amino terminal domain of the GR (asparagine to serine, codon 363) was also discovered in exon 2 of the other allele (G1220) in the proband, in one of her affected brothers and in her unaffected sister. The functional importance of this mutation was tested in a cotransfection study using the recombinant expression vector pRShGR-Ser363 and the glucocorticoid responsive vector mouse mammary tumor virus-chloramphenicol transferase. This amino acid substitution did not alter the function of the glucocorticoid receptor. Using reverse transcription-polymerase chain reaction we could only identify messenger RNA transcripts of the G1220-allele but not of the delta 4-allele in the affected members of this family who were heterozygous for the G1220 mutation. This deletion in the glucocorticoid receptor gene was, thus, associated with the expression of only one allele and a decrease of GR protein by 50% in affected members of this glucocorticoid resistant family. The mutation identified in exon 2 did not segregate with the disease and appears to be of no functional significance. The presence of the null allele was apparently compensated for by increased cortisol production at the expense of concurrent hyperandrogenism.
This article has been cited by other articles:
![]() |
M Neves-Pereira, B Muller, D Massie, J H G Williams, P C M O'Brien, A Hughes, S-B Shen, D. S. Clair, and Z Miedzybrodzka Deregulation of EIF4E: a novel mechanism for autism J. Med. Genet., November 1, 2009; 46(11): 759 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. Ge, C. Matte-Martone, J. Goodwin, W. D. Shlomchik, M. J. Mamula, A. Kooshkabadi, M. P. Hardy, and D. Geller Characterization of a Novel Gain of Function Glucocorticoid Receptor Knock-in Mouse J. Biol. Chem., March 6, 2009; 284(10): 6249 - 6259. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, T. Kino, T. Ichijo, W. Jubiz, L. Mejia, K. Zachman, and G. P. Chrousos A Novel Point Mutation in Helix 11 of the Ligand-Binding Domain of the Human Glucocorticoid Receptor Gene Causing Generalized Glucocorticoid Resistance J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3986 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jewell and J. A. Cidlowski Molecular Evidence for a Link between the N363S Glucocorticoid Receptor Polymorphism and Altered Gene Expression J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3268 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Bonifati, S F Witchel, M Ermani, E P Hoffman, C Angelini, and E Pegoraro The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1177 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Geller, J. Zhang, M.-C. Zennaro, A. Vallo-Boado, J. Rodriguez-Soriano, L. Furu, R. Haws, D. Metzger, B. Botelho, L. Karaviti, et al. Autosomal Dominant Pseudohypoaldosteronism Type 1: Mechanisms, Evidence for Neonatal Lethality, and Phenotypic Expression in Adults J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1429 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, T. Kino, T. Ichijo, K. Zachman, A. Alatsatianos, and G. P. Chrousos Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGR{alpha}R477H and hGR{alpha}G679S Associated with Generalized Glucocorticoid Resistance J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1535 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Russcher, P. Smit, E. F. C. van Rossum, E. L. T. van den Akker, A. O. Brinkmann, L. J. M. de Heide, F. H. de Jong, J. W. Koper, and S. W. J. Lamberts Strategies for the Characterization of Disorders in Cortisol Sensitivity J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A.E. Irving, L. Minto, S. Bailey, and A. G. Hall Loss of Heterozygosity and Somatic Mutations of the Glucocorticoid Receptor Gene Are Rarely Found at Relapse in Pediatric Acute Lymphoblastic Leukemia but May Occur in a Subpopulation Early in the Disease Course Cancer Res., November 1, 2005; 65(21): 9712 - 9718. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J.E. Tissing, J. P.P. Meijerink, M. L. den Boer, B. Brinkhof, E. F.C. van Rossum, E. R. van Wering, J. W. Koper, P. Sonneveld, and R. Pieters Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia Clin. Cancer Res., August 15, 2005; 11(16): 6050 - 6056. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, T. Kino, E. Souvatzoglou, A. Vottero, N. Bhattacharyya, and G. P. Chrousos Natural Glucocorticoid Receptor Mutants Causing Generalized Glucocorticoid Resistance: Molecular Genotype, Genetic Transmission, and Clinical Phenotype J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1939 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F.C. van Rossum and S. W.J. Lamberts Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357. [Abstract] [Full Text] |
||||
![]() |
R. Rosmond, B. J. Morris, R. C.Y. Lin, and X. L. Wang Glucocorticoid Receptor Gene and Coronary Artery Disease: Right Idea, Wrong Gene Variant? * Response Hypertension, August 1, 2003; e4(2): . [Full Text] [PDF] |
||||
![]() |
R. C.Y. Lin, X. L. Wang, and B. J. Morris Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant Hypertension, March 1, 2003; 41(3): 404 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F.C. van Rossum, J. W. Koper, N. A.T.M. Huizenga, A. G. Uitterlinden, J. A.M.J.L. Janssen, A. O. Brinkmann, D. E. Grobbee, F. H. de Jong, C. M. van Duyn, H. A.P. Pols, et al. A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels Diabetes, October 1, 2002; 51(10): 3128 - 3134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Yudt and J. A. Cidlowski The Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene Mol. Endocrinol., August 1, 2002; 16(8): 1719 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vottero, T. Kino, H. Combe, P. Lecomte, and G. P. Chrousos A Novel, C-Terminal Dominant Negative Mutation of the GR Causes Familial Glucocorticoid Resistance through Abnormal Interactions with p160 Steroid Receptor Coactivators J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2658 - 2667. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Mendonca, M. V. Leite, M. de Castro, T. Kino, L. L. K. Elias, T. A. S. Bachega, I. J. P. Arnhold, G. P. Chrousos, and A. C. Latronico Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1805 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kino, R. H. Stauber, J. H. Resau, G. N. Pavlakis, and G. P. Chrousos Pathologic Human GR Mutant Has a Transdominant Negative Effect on the Wild-Type GR by Inhibiting Its Translocation into the Nucleus: Importance of the Ligand-Binding Domain for Intracellular GR Trafficking J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5600 - 5608. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Lange, C. M. Segeren, J. W. Koper, E. Wiemer, P. Sonneveld, A. O. Brinkmann, A. White, I. J. Brogan, F. H. de Jong, and S. W. J. Lamberts Expression in Hematological Malignancies of a Glucocorticoid Receptor Splice Variant That Augments Glucocorticoid Receptor-mediated Effects in Transfected Cells Cancer Res., May 1, 2001; 61(10): 3937 - 3941. [Abstract] [Full Text] |
||||
![]() |
N. A. T. M. Huizenga, P. de Lange, J. W. Koper, W. W. de Herder, R. Abs, J. H. L. M. v. Kasteren, F. H. de Jong, and S. W. J. Lamberts Five Patients with Biochemical and/or Clinical Generalized Glucocorticoid Resistance without Alterations in the Glucocorticoid Receptor Gene J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2076 - 2081. [Abstract] [Full Text] |
||||
![]() |
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo Cancer Res., April 1, 2000; 60(7): 2056 - 2062. [Abstract] [Full Text] |
||||
![]() |
Adrenal Hyperandrogenism in Children J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4431 - 4435. [Full Text] |
||||
![]() |
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension Hypertension, December 1, 1999; 34(6): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Keightley, A. J. Curtis, S. Chu, and P. J. Fuller Structural Determinants of Cortisol Resistance in the Guinea Pig Glucocorticoid Receptor Endocrinology, May 1, 1998; 139(5): 2479 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921. [Abstract] [Full Text] |
||||
![]() |
N. A. T. M. Huizenga, J. W. Koper, P. de Lange, H. A. P. Pols, R. P. Stolk, H. Burger, D. E. Grobbee, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts A Polymorphism in the Glucocorticoid Receptor Gene May Be Associated with an Increased Sensitivity to Glucocorticoids in Vivo J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 144 - 151. [Abstract] [Full Text] |
||||
![]() |
S. Karanth, A. C. E. Linthorst, G. K. Stalla, N. Barden, F. Holsboer, and J. M. H. M. Reul Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function Endocrinology, August 1, 1997; 138(8): 3476 - 3485. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Lange, J. W. Koper, N. A. T. M. Huizenga, A. O. Brinkmann, F. H. de Jong, M. Karl, G. P. Chrousos, and S. W. J. Lamberts Differential Hormone-Dependent Transcriptional Activation and -Repression by Naturally Occurring Human Glucocorticoid Receptor Variants Mol. Endocrinol., July 1, 1997; 11(8): 1156 - 1164. [Abstract] [Full Text] |
||||
![]() |
N. B. E. Oldenburg, R. B. Evans-Storms, and J. A. Cidlowski In Vivo Resistance to Glucocorticoid-Induced Apoptosis in Rat Thymocytes with Normal Steroid Receptor Function in Vitro Endocrinology, February 1, 1997; 138(2): 810 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Richeldi, R Sorrentino, and C Saltini HLA-DPB1 glutamate 69: a genetic marker of beryllium disease Science, October 8, 1993; 262(5131): 242 - 244. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |